Skip to main content

Advertisement

Figure 1 | Malaria Journal

Figure 1

From: Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique

Figure 1

The Frequency of Pfdhps (A) and Pfdhfr (B) haplotypes in December 2001 (black bars) and January 2003 (red bars) in Manhiça district. After removing the PCR negatives and the samples with mixed haplotype infections (where a major haplotype could not be determined), for Pfdhps, N = 104 and 115 and for Pfdhfr, N = 99 and 109 from survey 1 and 2, respectively.

Back to article page